Omar Alhalabi
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, Renal cell carcinoma treatment, Epigenetics and DNA Methylation
Most-Cited Works
- → Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma(2020)305 cited
- → 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy(2021)211 cited
- → Factor XII and uPAR upregulate neutrophil functions to influence wound healing(2018)141 cited
- → Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016(2021)112 cited
- → Reduced thrombosis in Klkb1−/− mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor(2014)85 cited
- → MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers(2022)66 cited
- → Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases(2018)66 cited
- → Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer(2017)54 cited
- → Immunotherapy for Melanoma(2020)51 cited
- → Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas(2022)37 cited